Dynamics of immune-mediated thyroid dysfunction in patients with advanced renal cell carcinoma receiving checkpoint inhibitor therapy.

被引：0
|
作者：
Osorio, Juan Carlos
Patil, Sujata
Coskey, Devyn Taylor
Carlo, Maria Isabel
Feldman, Darren R.
Hellmann, Matthew David
Voss, Martin Henner
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e16071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16071
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Immune-mediated colitis after resumption of immune checkpoint inhibitor therapy.
    Abu-Sbeih, Hamzah
    Ali, Faisal
    Naqash, Abdul Rafeh
    Owen, Dwight Hall
    Patel, Sandip H.
    Otterson, Gregory Alan
    Kendra, Kari Lynn
    Ricciuti, Biagio
    Chiari, Rita
    De Giglio, Andrea
    Sleiman, Joseph
    Funchain, Pauline
    Beatriz, Wills
    Zhang, Jiajia
    Naidoo, Jarushka
    Philpott, Jessica
    Gao, Jianjun
    Subudhi, Sumit Kumar
    Wang, Yinghong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Characterization of the onset of thyroid function (TF) abnormalities in patients receiving immune checkpoint inhibitor (CPI) therapy.
    Elnair, Radowan
    Chang, Guy Vin
    Sethi, Prince
    Abdullah, Hafez Mohammad
    Zhao, Jing
    Griebeler, Marcio L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Immune checkpoint inhibitor combination therapy leads to more nephrotoxicity in advanced renal cell carcinoma patients
    Song, Yuxuan
    Han, Songchen
    Xu, Tao
    WORLD JOURNAL OF UROLOGY, 2023, 41 (07) : 1991 - 1992
  • [4] Immune checkpoint inhibitor combination therapy leads to more nephrotoxicity in advanced renal cell carcinoma patients
    Yuxuan Song
    Songchen Han
    Tao Xu
    World Journal of Urology, 2023, 41 : 1991 - 1992
  • [5] Immune-mediated colitis after immune checkpoint inhibitor therapy
    Giesler, Sophie
    Riemer, Roxane
    Lowinus, Theresa
    Zeiser, Robert
    TRENDS IN MOLECULAR MEDICINE, 2025, 31 (03) : 265 - 280
  • [6] Severe immune-mediated Hepatitis on Checkpoint Inhibitor Therapy
    Kirsten, H.
    Ziemer, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 92 - 92
  • [7] Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
    Lavoie, Jean-Michel
    Baichoo, Priya
    Chavez, Elizabeth
    Nappi, Lucia
    Khalaf, Daniel
    Kollmannsberger, Christian K.
    Chi, Kim N.
    Weng, Andrew
    Steidl, Christian
    Eigl, Bernhard J.
    Nissen, Michael
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis
    An-ju Tan
    Dun-chang Mo
    Ka Wu
    Hong-mei Pan
    Dong-mei Wang
    Xing-xin Xu
    Min-hong Chen
    Shu-ying Pan
    Rou Li
    Wen-jiao lian
    Meng-han Wei
    World Journal of Urology, 2023, 41 : 1563 - 1571
  • [9] Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis
    Tan, An-ju
    Mo, Dun-chang
    Wu, Ka
    Pan, Hong-mei
    Wang, Dong-mei
    Xu, Xing-xin
    Chen, Min-hong
    Pan, Shu-ying
    Li, Rou
    Lian, Wen-jiao
    Wei, Meng-han
    WORLD JOURNAL OF UROLOGY, 2023, 41 (06) : 1563 - 1571
  • [10] Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma
    Ghoreifi, Alireza
    Vaishampayan, Ulka
    Yin, Ming
    Psutka, Sarah P.
    Djaladat, Hooman
    JAMA ONCOLOGY, 2024, 10 (02) : 240 - 248
12345